Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
ConditionCoagulopathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-18
SponsorIndiana University
About this trial
The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.
Eligibility criteria
Qualifiers
None
Disqualifiers
Known disorder of coagulation pathway(s)
Administration of medications that may alter the coagulation cascade
Patients in foster care or wards of the court
Trial design
Treatments tested in this trial
- Thromboelastography (TEG 6S)
Treatment groups
125 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov